Top Health News

NEW YORK (Reuters) – Men diagnosed with testicular cancer at 40 years of geezerhood or senior have twice the venture of dying from the disease as junior patients, according to a think of nearly 28,000 men.

This was true modify when initial communication and the extent of the disease were condemned into account, according to findings published in the Journal of Clinical Oncology.

"This think comprehensively documents, for the prototypal time, to our knowledge, the effect of geezerhood on TC-specific mortality, while taking into statement disease characteristics, communication factors and socio-demographic variables," wrote Lois Travis, of the University of metropolis Medical Center, New York, along with colleagues from Oslo, Norway.

The investigate is based on accumulation from the Surveillance, Epidemiology and End Results program, a source for U.S. cancer statistics at the U.S. National person Institute. Travis and her aggroup calculated hazard ratios for 10-year testicular cancer mortality.

Mortality was doubled in patients diagnosed over the geezerhood of 40, the think found. But, those diagnosed after 1987 were inferior probable to die during follow-up than men diagnosed earlier, possibly due to the launching of a destined kind of chemotherapy about 10 years earlier.

"The question, however, relic whether connexion between socioeconomic variables and mortality reflect differences in the health tending system's noesis to offer prizewinning treatment, the patient's willingness to accept intensive communication with a non-negligible venture of inauspicious effects, or the physician's noesis of prizewinning communication approaches," they wrote.

Several factors may statement for the age-related mortality difference, including the fact that many senior patients are often not aerated with the same intensity as junior patients, the researchers said.

The researchers advisable giving more attention to the tending of senior patients as well as those of grouping of modify socioeconomic position for the prizewinning results.

"In a cancer that is so highly curable, some impact that confers an accumulated venture of disease-specific mortality staleness be identified, and interventional strategies adopted," they said.

SOURCE: http://bit.ly/fGNEw9

(Reporting by Reuters Health; redaction by Elaine Lies)

Source